Pfizer (NYSE: PFE) is a great example, with its shares down around 57% below the previous high. When a stock plunges as much ...

Many investors love the "big mo." That's short for "big momentum." Stocks that are on a roll often keep the good times going.

The tariff war the U.S. is waging against most of the world stabilized somewhat earlier this month. But let's face facts -- ...

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Amphastar ...

Six so-called patient advocacy groups are working to advance corporate profits in the pharmaceutical industry by routinely ...

2 M&A plays a key role in bringing highly lucrative medications to market, as large pharmaceutical companies often look to invest in young biotechnology companies for their innovative products.

The White House requested the original assessment in February as it was preparing Mr. Trump’s Alien Enemies Act proclamation.

When multibillion-pound global corporations invest huge sums in medical companies to develop new treatments for serious ...

What a pity that a Republican administration needs to be reminded that this misguided policy won’t make America healthy or great.

Shares of the leading digital platform for U.S. medical professionals, Doximity (NYSE: DOCS), were down 14% as of noon ET ...

A Bengaluru pharmaceutical company has pioneered a technology to remove organic solvents in drug production, enhancing safety ...